세계의 알레르기 예방 주사 시장

Global Allergy Shots Market to Reach US$4.4 Billion by 2030

The global market for Allergy Shots estimated at US$2.6 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. SLIT Tablets Allergy Shots, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Oral Allergy Shots segment is estimated at 10.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$708.8 Million While China is Forecast to Grow at 12.4% CAGR

The Allergy Shots market in the U.S. is estimated at US$708.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$880.6 Million by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Allergy Shots Market - Key Trends & Drivers Summarized

Why Are Allergy Shots Evolving Into a Cornerstone of Long-Term Allergy Treatment?

Allergy shots, medically known as subcutaneous immunotherapy (SCIT), are increasingly recognized as a central component in the comprehensive management of chronic allergic conditions. Unlike standard medications that only suppress symptoms, allergy shots work by gradually retraining the immune system to become less sensitive to allergens. This form of immunotherapy is especially valuable for individuals with severe or persistent allergies to environmental triggers like pollen, mold, dust mites, or animal dander. The treatment involves a phased schedule-initially frequent doses to build tolerance, followed by maintenance doses over a few years. The outcome for many patients is reduced symptom severity, decreased reliance on daily antihistamines, and a significant improvement in quality of life. This long-term effect is particularly appealing in cases where allergies disrupt sleep, productivity, or daily functioning. What differentiates allergy shots is their disease-modifying potential: rather than just masking allergic reactions, they aim to alter the immune system’s response at its root. As allergy rates rise globally, this preventive capability is gaining more relevance. Pediatric use is also growing, as early immunotherapy can potentially change a child’s allergic trajectory before symptoms worsen or progress into asthma. Moreover, the therapy is supported by a growing body of clinical evidence and endorsements from global health authorities, giving physicians and patients the confidence to invest in this multi-year, outcome-focused treatment approach.

How Are Technological and Clinical Innovations Refining Allergy Shot Therapy?

Modern advancements in allergy diagnostics and immunotherapy delivery are refining the way allergy shots are formulated, administered, and monitored. Traditionally, patients underwent skin or blood testing to identify allergen sensitivities, but newer tools such as component-resolved diagnostics allow for a deeper understanding of which specific allergen proteins trigger immune reactions. This granularity supports the development of more personalized and targeted immunotherapy formulations, increasing the success rate of desensitization. Additionally, manufacturers are producing highly standardized allergen extracts, ensuring consistent potency and reducing variability in outcomes. From an administration standpoint, innovations such as cluster and rush immunotherapy allow patients to reach maintenance doses more quickly and with fewer clinic visits, enhancing convenience while maintaining safety protocols. Digital health platforms and mobile applications are being integrated into treatment regimens to assist with scheduling, dose tracking, and patient education. These platforms also enable real-time communication between patients and allergists, improving adherence and reducing dropout rates. Furthermore, research is ongoing into next-generation adjuvants and delivery methods that could one day eliminate the need for injections altogether, potentially shifting allergy immunotherapy to a needle-free model. The synergy between clinical precision and technological support is not only improving patient outcomes but also broadening the appeal and practicality of allergy shots in routine allergy care.

What Environmental and Societal Shifts Are Fueling Interest in Allergy Immunotherapy?

Wider adoption of allergy shots is being shaped by pressing environmental and societal shifts that are increasing the burden of allergic diseases worldwide. One of the most significant drivers is environmental degradation, including rising air pollution and climate change, which has extended pollen seasons and intensified allergenic exposure across regions. Urban populations, in particular, are experiencing higher rates of allergic rhinitis and asthma, conditions often triggered or worsened by airborne particulates. In parallel, lifestyle changes-such as spending more time indoors, using processed products, and reduced early-life exposure to microbes-are believed to contribute to the rising prevalence of allergic sensitizations. On the societal front, there’s a growing consumer preference for treatments that go beyond temporary relief and offer long-term health benefits. Allergy shots fulfill this demand by addressing allergies at the immunological level, rather than simply masking symptoms. Awareness campaigns, patient advocacy groups, and more open dialogue between patients and healthcare providers have also helped destigmatize allergy treatment, encouraging more people to pursue immunotherapy. Moreover, families are becoming more proactive in managing children’s allergies early in life, leading to a rise in pediatric immunotherapy. Increasingly, employers and educational institutions are recognizing how allergies impact performance, attendance, and healthcare costs, making allergy management a shared priority. These changing environmental and cultural dynamics are creating a fertile ground for the widespread adoption of allergy immunotherapy as a sustainable solution to an expanding global health challenge.

What Are the Key Drivers Propelling Growth in the Allergy Shots Market?

The expansion of the allergy shots market is underpinned by a range of clinical, economic, and behavioral drivers that are converging in powerful ways. The most immediate growth catalyst is the escalating incidence of allergies worldwide, especially in densely populated and industrializing regions where environmental allergens are abundant. Allergy shots offer an effective response to this trend, particularly for patients with multiple sensitivities or those unresponsive to conventional medications. From an economic perspective, allergy shots present a compelling long-term value proposition: they reduce the need for repeated doctor visits, emergency care, and long-term medication use. Insurance providers and public health systems are beginning to recognize these savings, leading to improved reimbursement structures and wider treatment access. Another key driver is the shift toward precision medicine, as diagnostic tools and individualized immunotherapy regimens become more advanced. These enhancements improve treatment outcomes and patient satisfaction, encouraging broader acceptance of the therapy. There’s also increasing collaboration between allergists, primary care providers, and pharmacists, ensuring more consistent patient referrals and follow-through. The rise of telehealth and patient support technologies is removing logistical barriers and making treatment more manageable across diverse geographies and demographics. Additionally, pharmaceutical companies are investing in education campaigns and training programs to equip healthcare professionals with the tools needed to implement immunotherapy effectively. Altogether, these drivers are fueling a robust, upward trajectory for the allergy shots market, positioning it as a pivotal solution in the ongoing battle against chronic allergic disease.

SCOPE OF STUDY:

The report analyzes the Allergy Shots market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots, Other Allergy Shot Products); Immunotherapy (Sublingual Immunotherapy, Subcutaneous Immunotherapy, Other Immunotherapies); Indication (Allergic Rhinitis Indication, Allergic Asthma Indication, Food Allergy Indication, Atopic Dermatitis Indication, Other Indications); Allergen (Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen, Other Allergens); Distribution Channel (Institutional Sales Distribution Channel, Retail Sales Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Aimmune Therapeutics
• ALK-Abello A/S
• Allergopharma (Merck KGaA)
• Allergy Therapeutics
• Allovate, LLC
• Anergis SA
• Arrayit Corporation
• Biomay AG
• DBV Technologies
• Dermapharm Holding SE
• GlaxoSmithKline plc
• HAL Allergy Group
• HollisterStier Allergy (Jubilant Pharma)
• Intrommune Therapeutics
• LETIPharma
• Pfizer Inc.
• Stallergenes Greer
• Torii Pharmaceutical Co., Ltd.
• UCB S.A.
• Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Allergy Shots - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Severe Allergies and Asthma Spurs Demand for Long-Term Immunotherapy Solutions
  • Growing Recognition of Allergy Shots as Disease-Modifying Treatment Propels Adoption Among Chronic Sufferers
  • Increased Diagnosis Rates and Specialist Referrals Expand the Addressable Market for Allergy Injections
  • Here's How Advancements in Allergen Extract Standardization Strengthen Clinical Confidence in Allergy Shots
  • Rising Pediatric Sensitization Rates Drive Early Intervention and Long-Term Allergy Management Demand
  • Expanding Awareness of Sublingual Immunotherapy Alternatives Throws the Spotlight on Differentiated Use-Cases
  • Integration of Allergy Shots Into Chronic Care Plans Accelerates Demand in Multi-Specialty Clinics
  • Here's the Story: Shift from Symptom Management to Root Cause Treatment Fuels Demand for SCIT Protocols
  • Growing Burden of Environmental Allergens in Urban Areas Drives Adoption of Preventive Injection Therapies
  • Innovations in Injection Schedules and Cluster Protocols Enhance Patient Convenience and Compliance
  • Rural and Underserved Market Outreach Initiatives Generate Opportunities for Immunotherapy Access
  • Rising Comorbidity Awareness (e.g., asthma, sinusitis) Throws the Spotlight on Allergy Shots as Adjunct Therapy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Allergy Shots Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for SLIT Tablets Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for SLIT Tablets Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for SLIT Tablets Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Oral Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Oral Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Oral Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Injection Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Injection Allergy Shots by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Injection Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Allergy Shot Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Allergy Shot Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Allergy Shot Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Food Allergy Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Food Allergy Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Food Allergy Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Atopic Dermatitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Atopic Dermatitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Atopic Dermatitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Allergic Rhinitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Allergic Rhinitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Allergic Rhinitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Allergic Asthma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Allergic Asthma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Allergic Asthma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Pollens Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Pollens Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Pollens Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for House Dust Mites Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for House Dust Mites Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for House Dust Mites Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Mold Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Mold Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Mold Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Animal Dander Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Animal Dander Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Animal Dander Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Bee Venom Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Bee Venom Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Bee Venom Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Cockroaches / Insects Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Cockroaches / Insects Allergen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Cockroaches / Insects Allergen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other Allergens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Other Allergens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Institutional Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Institutional Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Institutional Sales Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Retail Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Retail Sales Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Retail Sales Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Sublingual Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Sublingual Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Sublingual Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Subcutaneous Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Subcutaneous Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: World 16-Year Perspective for Subcutaneous Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Other Immunotherapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Other Immunotherapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: World 16-Year Perspective for Other Immunotherapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 68: USA Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: USA 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: USA 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: USA 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 80: USA Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: USA Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: USA 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Canada 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Canada 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Canada 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 92: Canada Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Canada Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Canada 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 95: Canada Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Canada Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Canada 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• JAPAN
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Japan 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Japan 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 104: Japan Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Japan Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Japan 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 107: Japan Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Japan Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Japan 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 110: Japan Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Japan Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Japan 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• CHINA
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 113: China Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: China 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 116: China Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: China 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 119: China Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: China Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: China 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 122: China Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: China Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: China 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 125: China Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: China Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: China 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• EUROPE
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Allergy Shots by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Allergy Shots by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Europe 16-Year Perspective for Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Europe 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Europe 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Europe 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Europe Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Europe 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Europe 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• FRANCE
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 146: France Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: France Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: France 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 149: France Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: France 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: France 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 155: France Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: France Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: France 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 158: France Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: France Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: France 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• GERMANY
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 161: Germany Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Germany Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Germany 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Germany 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Germany 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Germany Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Germany 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 173: Germany Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Germany Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Germany 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 176: Italy Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Italy Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Italy 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Italy 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Italy 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 185: Italy Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Italy Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Italy 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 188: Italy Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Italy Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Italy 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 191: UK Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: UK Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: UK 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 194: UK Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: UK 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 197: UK Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UK Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UK 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 200: UK Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UK Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: UK 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 203: UK Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: UK Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: UK 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 206: Spain Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Spain Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Spain 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Spain 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 212: Spain Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Spain Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Spain 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 215: Spain Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Spain Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Spain 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 218: Spain Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Spain Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Spain 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 221: Russia Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Russia Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Russia 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Russia 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 227: Russia Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Russia Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Russia 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 230: Russia Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Russia Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Russia 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 233: Russia Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Russia Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Russia 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Europe Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Europe 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Europe Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Europe 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Europe Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Europe Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Europe 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Europe Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Europe Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Europe 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Asia-Pacific Historic Review for Allergy Shots by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Asia-Pacific 16-Year Perspective for Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Asia-Pacific Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Asia-Pacific 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 263: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Asia-Pacific Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Asia-Pacific 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Asia-Pacific Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Asia-Pacific 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 269: Australia Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Australia Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Australia 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Australia 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 275: Australia Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Australia Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Australia 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 278: Australia Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Australia Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Australia 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 281: Australia Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Australia Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Australia 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• INDIA
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 284: India Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: India Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: India 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 287: India Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: India 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 290: India Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: India Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: India 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 293: India Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: India Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: India 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 296: India Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: India Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: India 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 299: South Korea Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: South Korea Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: South Korea 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: South Korea 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 305: South Korea Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: South Korea Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: South Korea 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 308: South Korea Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: South Korea Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: South Korea 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 311: South Korea Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: South Korea Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: South Korea 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Asia-Pacific Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Asia-Pacific 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Asia-Pacific Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Asia-Pacific 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 323: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Asia-Pacific Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Rest of Asia-Pacific 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 326: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Asia-Pacific Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Rest of Asia-Pacific 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 329: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 330: Latin America Historic Review for Allergy Shots by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Latin America 16-Year Perspective for Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Latin America 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Latin America 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 338: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Latin America Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Latin America 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 341: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Latin America Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Latin America 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 344: Latin America Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Latin America Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Latin America 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 347: Argentina Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Argentina Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Argentina 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Argentina 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 353: Argentina Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Argentina Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Argentina 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 356: Argentina Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Argentina Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Argentina 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 359: Argentina Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Argentina Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Argentina 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 362: Brazil Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Brazil Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Brazil 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Brazil 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 368: Brazil Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Brazil Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Brazil 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 371: Brazil Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Brazil Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Brazil 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 374: Brazil Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Brazil Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: Brazil 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 377: Mexico Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Mexico Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: Mexico 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Mexico 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 383: Mexico Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Mexico Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Mexico 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 386: Mexico Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Mexico Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Mexico 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 389: Mexico Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Mexico Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Mexico 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Latin America Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Latin America 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Latin America Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Rest of Latin America 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 401: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Latin America Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Rest of Latin America 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 404: Rest of Latin America Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Latin America Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Latin America 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 407: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 408: Middle East Historic Review for Allergy Shots by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Middle East 16-Year Perspective for Allergy Shots by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 412: Middle East 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 415: Middle East 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 416: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Middle East Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 418: Middle East 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 419: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Middle East Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 421: Middle East 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 422: Middle East Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Middle East Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 424: Middle East 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 425: Iran Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Iran Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 427: Iran 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 430: Iran 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 431: Iran Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Iran Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 433: Iran 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 434: Iran Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Iran Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 436: Iran 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 437: Iran Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Iran Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 439: Iran 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 440: Israel Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Israel Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 442: Israel 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 445: Israel 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 446: Israel Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Israel Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 448: Israel 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 449: Israel Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Israel Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 451: Israel 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 452: Israel Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Israel Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 454: Israel 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Saudi Arabia Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 457: Saudi Arabia 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Saudi Arabia Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 463: Saudi Arabia 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 464: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Saudi Arabia Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 466: Saudi Arabia 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 467: Saudi Arabia Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Saudi Arabia Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 469: Saudi Arabia 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 470: UAE Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: UAE Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 472: UAE 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 475: UAE 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 476: UAE Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: UAE Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 478: UAE 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 479: UAE Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: UAE Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 481: UAE 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 482: UAE Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: UAE Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 484: UAE 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: Rest of Middle East Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 487: Rest of Middle East 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Rest of Middle East Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 493: Rest of Middle East 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 494: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Rest of Middle East Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 496: Rest of Middle East 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 497: Rest of Middle East Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Rest of Middle East Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 499: Rest of Middle East 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030
• AFRICA
  • Allergy Shots Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 500: Africa Recent Past, Current & Future Analysis for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Africa Historic Review for Allergy Shots by Product - SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 502: Africa 16-Year Perspective for Allergy Shots by Product - Percentage Breakdown of Value Sales for SLIT Tablets Allergy Shots, Oral Allergy Shots, Injection Allergy Shots and Other Allergy Shot Products for the Years 2014, 2025 & 2030
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Allergy Shots by Indication - Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 505: Africa 16-Year Perspective for Allergy Shots by Indication - Percentage Breakdown of Value Sales for Food Allergy Indication, Atopic Dermatitis Indication, Other Indications, Allergic Rhinitis Indication and Allergic Asthma Indication for the Years 2014, 2025 & 2030
  • TABLE 506: Africa Recent Past, Current & Future Analysis for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Africa Historic Review for Allergy Shots by Allergen - Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 508: Africa 16-Year Perspective for Allergy Shots by Allergen - Percentage Breakdown of Value Sales for Pollens Allergen, House Dust Mites Allergen, Mold Allergen, Animal Dander Allergen, Bee Venom Allergen, Cockroaches / Insects Allergen and Other Allergens for the Years 2014, 2025 & 2030
  • TABLE 509: Africa Recent Past, Current & Future Analysis for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 510: Africa Historic Review for Allergy Shots by Distribution Channel - Institutional Sales Distribution Channel and Retail Sales Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 511: Africa 16-Year Perspective for Allergy Shots by Distribution Channel - Percentage Breakdown of Value Sales for Institutional Sales Distribution Channel and Retail Sales Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 512: Africa Recent Past, Current & Future Analysis for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 513: Africa Historic Review for Allergy Shots by Immunotherapy - Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 514: Africa 16-Year Perspective for Allergy Shots by Immunotherapy - Percentage Breakdown of Value Sales for Sublingual Immunotherapy, Subcutaneous Immunotherapy and Other Immunotherapies for the Years 2014, 2025 & 2030

IV. COMPETITION